Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.230
+0.010 (0.82%)
Aug 12, 2026, 1:49 PM EDT - Market open
Biofrontera Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | - | - | 1.34 | 17.21 | 24.55 |
Short-Term Investments | - | - | - | 0.08 | 10.55 | - |
Cash & Short-Term Investments | - | - | - | 1.42 | 27.76 | 24.55 |
Cash Growth | - | - | - | -94.88% | 13.08% | 203.78% |
Accounts Receivable | - | - | - | 5.16 | 3.75 | 3.78 |
Other Receivables | - | - | - | - | 3.66 | 8.65 |
Total Trade Receivables | - | - | - | 5.16 | 7.41 | 12.43 |
Inventory | 1.23 | 1.43 | 6.65 | 10.91 | 7.17 | 4.46 |
Other Current Assets | 1.06 | 2.28 | 2.83 | 5.58 | 0.81 | 4.99 |
Total Current Assets | 2.29 | 3.71 | 9.47 | 23.08 | 43.14 | 46.42 |
Net Property, Plant & Equipment | 5.07 | 3.74 | 0.98 | 1.75 | 1.58 | 0.27 |
Other Intangible Assets | 2.61 | 2.65 | 0.04 | 2.63 | 3.03 | 3.45 |
Other Long-Term Assets | 3.95 | 4.09 | 0.38 | 0.48 | 3.13 | 3.08 |
Total Assets | 24.79 | 28.56 | 22.1 | 27.93 | 50.88 | 53.22 |
Accounts Payable | 4.95 | 6.67 | 7.2 | 9.01 | 2.59 | 0.94 |
Accrued Expenses | 5.47 | 4.9 | 4.27 | 4.49 | 10.86 | 9.65 |
Short-Term Debt | - | - | - | 3.9 | - | - |
Current Portion of Leases | 0.51 | 0.33 | 0.55 | 0.69 | 0.5 | - |
Other Current Liabilities | - | - | - | - | 6.94 | 3.24 |
Total Current Liabilities | 10.92 | 11.9 | 12.02 | 18.09 | 20.89 | 13.84 |
Long-Term Debt | 4.72 | 4.59 | 4.1 | - | - | - |
Long-Term Leases | 2.5 | 1.24 | 0.28 | 0.8 | 0.85 | - |
Other Long-Term Liabilities | 0.58 | 0.36 | 1.27 | 4.25 | 5.26 | 28.05 |
Total Long-Term Liabilities | 7.79 | 6.19 | 5.65 | 5.05 | 6.11 | 28.05 |
Total Liabilities | 18.72 | 18.08 | 17.67 | 23.14 | 27.01 | 41.88 |
Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | 0.02 |
Additional Paid-in Capital | 138.76 | 138.41 | 121.83 | 104.44 | 103.4 | 90.2 |
Retained Earnings | -132.7 | -127.95 | -117.41 | -99.65 | -79.52 | -78.88 |
Shareholders' Equity | 6.07 | 10.48 | 4.43 | 4.79 | 23.88 | 11.34 |
Total Liabilities & Equity | 24.79 | 28.56 | 22.1 | 27.93 | 50.88 | 53.22 |
Total Debt | 7.72 | 6.16 | 4.92 | 5.4 | 1.35 | 0 |
Net Cash (Debt) | -7.72 | -6.16 | -4.92 | -3.98 | 26.41 | 24.55 |
Net Cash Growth | - | - | - | - | 7.60% | 203.78% |
Net Cash Per Share | -0.71 | -0.61 | -0.89 | -2.57 | 24.99 | 55.73 |
Book Value | 6.07 | 10.48 | 4.43 | 4.79 | 23.88 | 11.34 |
Book Value Per Share | 0.56 | 1.03 | 0.80 | 3.10 | 22.59 | 25.74 |
Tangible Book Value | 3.46 | 7.83 | 4.4 | 2.16 | 20.85 | 7.89 |
Tangible Book Value Per Share | 0.32 | 0.77 | 0.80 | 1.40 | 19.72 | 17.91 |